Discontinued — last reported Q3 '25
ResMed Equity in income of investees increased by 13.4% to $1.72M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 412.8%, from $335.00K to $1.72M. This is a positive signal — higher values indicate stronger performance for this metric.
Positive values indicate successful performance of joint ventures or minority investments.
This reflects the company's share of the net earnings or losses of entities in which it holds a non-controlling interest...
Varies significantly based on the company's strategic partnership and joint venture structure.
dis_equity_in_income_of_investees| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$1.31M | -$1.39M | -$1.91M | -$2.63M | -$2.56M | -$2.03M | -$2.83M | -$183.00K | -$3.90M | $739.00K | $440.00K | $963.00K | $1.08M | $335.00K | $1.49M | $1.52M | $1.72M |
| QoQ Change | — | -6.0% | -38.1% | -37.3% | +2.6% | +20.8% | -39.3% | +93.5% | <-999% | +119.0% | -40.5% | +118.9% | +11.8% | -68.9% | +344.5% | +1.7% | +13.4% |
| YoY Change | — | — | — | — | -95.6% | -46.3% | -47.6% | +93.0% | -92.1% | +126.2% | +340.4% | +124.7% | +45.7% | -23.9% | +54.6% | +40.7% | +412.8% |